These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 1386503

  • 1. [Atrial natriuretic factor and cardiac insufficiency].
    Komajda M, Isnard R, Carayon A.
    Arch Mal Coeur Vaiss; 1992 Apr; 85(4):473-7. PubMed ID: 1386503
    [Abstract] [Full Text] [Related]

  • 2. [Atrial natriuretic factor. Current data and future perspectives].
    Michel JB, Arnal JF.
    Arch Mal Coeur Vaiss; 1990 Dec; 83(14):2111-21. PubMed ID: 2178342
    [Abstract] [Full Text] [Related]

  • 3. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
    Varin J, Duboc D, Weber S, Fouchard J, Schwartz JC, Muffat-Joly M, Guérin F.
    Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
    [Abstract] [Full Text] [Related]

  • 4. Atrial natriuretic factor in chronic heart failure.
    Northridge DB, McMurray J, Dargie HJ.
    Herz; 1991 Apr; 16(2):92-101. PubMed ID: 1829707
    [Abstract] [Full Text] [Related]

  • 5. [Use of natriuretic peptides in clinical practice].
    Lazúrová I, Kramer HJ.
    Vnitr Lek; 1994 Mar; 40(3):194-8. PubMed ID: 8184576
    [Abstract] [Full Text] [Related]

  • 6. Atrial natriuretic factor: implications in congestive heart failure and hypertension.
    Burnett JC.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():41-6. PubMed ID: 2528638
    [Abstract] [Full Text] [Related]

  • 7. [Atrial natriuretic factor as a marker of clinical severity in cardiac failure].
    Suchmanová-Lazúrová I, Rybár R, Majercák I, Valocík G, Fedorová E, Machánová Y, Tkácová R, Trejbal D.
    Vnitr Lek; 1993 Oct; 39(10):1003-7. PubMed ID: 8236862
    [Abstract] [Full Text] [Related]

  • 8. Atrial natriuretic factor in acute and chronic cardiac failure.
    Riegger GA, Kromer EP, Wild S, Hofbauer H, Klug ML, Kochsiek K.
    J Cardiovasc Pharmacol; 1987 Oct; 10 Suppl 6():S161-5. PubMed ID: 2485023
    [Abstract] [Full Text] [Related]

  • 9. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z, Karram T, Ellaham S, Winaver J, Hoffman A.
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
    Abassi ZA, Kelly G, Golomb E, Klein H, Keiser HR.
    J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
    Ma J, Peng A, Lin S.
    Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.